1-3 of 3
Steffen Boettcher
Close
Sort by
Journal Articles

TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms

Roman R. Schimmer, Larisa V. Kovtonyuk, Nancy Klemm, Jonas Fullin, Sebastian M. Stolz, Jan Mueller, Francisco Caiado, Kari J. Kurppa, Benjamin L. Ebert, Markus G. Manz, Steffen Boettcher
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3201–3206.
https://doi.org/10.1182/bloodadvances.2021005859
Published: 2022
Includes: Supplemental data
Journal Articles

CXCL12-abundant reticular cells are the major source of IL-6 upon LPS stimulation and thereby regulate hematopoiesis

Rahel C. Gerosa, Steffen Boettcher, Larisa V. Kovtonyuk, Annika Hausmann, Wolf-Dietrich Hardt, Juan Hidalgo, César Nombela-Arrieta, Markus G. Manz
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5002–5015.
https://doi.org/10.1182/bloodadvances.2021005531
Published: 2021
Includes: Supplemental data
Journal Articles

An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation

William Marion, Steffen Boettcher, Sonya Ruiz-Torres, Edroaldo Lummertz da Rocha, Vanessa Lundin, Vivian Morris, Stephanie Chou, Anna M. Zhao, Caroline Kubaczka, Olivia Aumais, Yosra Zhang, Akiko Shimamura, Thorsten M. Schlaeger, Trista E. North, Benjamin L. Ebert, Susanne I. Wells, George Q. Daley, R. Grant Rowe
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4679–4692.
https://doi.org/10.1182/bloodadvances.2020001593
Published: 2020
Includes: Supplemental data